BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership.
This milestone represents a new chapter for both BNP Paribas and Exane, thanks to the strong collaboration and long-standing commitments from the teams of both firms.
We’ve completed the acquisition of 100% of Exane!
With Exane’s expertise in #cashequities & #derivatives, @BNPParibas can offer institutional investors & corporates a full suite of services & solutions on equities ? https://t.co/exXfHWnR2Q pic.twitter.com/NJXnmvmro5— BNP Paribas CIB (@BNPParibasCIB) July 13, 2021
Leveraging Exane’s expertise in cash equities (execution and research) and derivatives, BNP Paribas will be able to provide a full suite of services on equities to Institutional investors and Corporates worldwide, positioning the bank as a leading provider in Global Equities.
Source: BNP Paribas
NEWSLETTER SIGN UP
And receive exclusive articles on securities markets
As Technology Evolves, Asset Managers Adapt and Innovate
Citi Changes Organizational Structure
SEC Charges Virtu for Disclosures Relating to Information Barriers
ICE Futures Singapore Partners with CoinDesk Indices
Related articles
-
Goldman Sachs intends to spin-out its tech platform, GS DAP, from its digital assets business.
-
Guidelines on weaknesses in banks' counterparty credit risk management will be published next month.
-
Buy side and sell side need to embrace technological advancements and automate the IPO process.
-
Alternatives are a strategic priority for many financial services firms.
-
The Dutch bank also used tokenized commercial paper as collateral.